TECLens
TECLens is a clinical-stage ophthalmic medical device company developing non-invasive refractive correction procedures. Their core technology utilizes corneal cross-linking (CXL) to reshape the cornea, offering a potential alternative to traditional refractive surgeries for vision correction, including presbyopia, keratoconus, and other vision disorders.
Funding Round: Series A
Funding Amount: $9.3M
Date: 11-Feb-2025
Investors: Johnson & Johnson Innovation – JJDC Inc., Yonjin Capital, Rimonci Capital, Sunmed Capital
Markets: MedTech, Ophthalmology
HQ: Stamford, Connecticut, United States
Founded: 2013
Website: https://teclens.com/
LinkedIn: https://www.linkedin.com/company/teclens/
Crunchbase: https://www.crunchbase.com/organization/teclens
Leave a Comment
Comments
No comments yet.